Inhibition of lung cancer growth and metastasis by DHA and its metabolite, RvD1, through miR-138-5p/FOXC1 pathway

BACKGROUND: Non small cell lung cancer (NSCLC) is one of the most common cancers in the world. DHA is known to be capable of suppressing NSCLC cell proliferation and metastasis. However, the mechanisms by which DHA exhibits its antitumor effects are unknown. Here we aimed to identify the effects and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Exp Clin Cancer Res
Autors principals: Bai, Xiaoming, Shao, Jiaofang, Zhou, Sujin, Zhao, Zhenggang, Li, Fanghong, Xiang, Rong, Zhao, Allan Z., Pan, Jinshun
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6884860/
https://ncbi.nlm.nih.gov/pubmed/31783879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1478-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars